vs

Side-by-side financial comparison of POTLATCHDELTIC CORP (PCH) and Bio-Techne (TECH). Click either name above to swap in a different company.

POTLATCHDELTIC CORP is the larger business by last-quarter revenue ($314.2M vs $295.9M, roughly 1.1× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 8.2%, a 4.6% gap on every dollar of revenue. On growth, POTLATCHDELTIC CORP posted the faster year-over-year revenue change (23.1% vs -6.4%). Over the past eight quarters, POTLATCHDELTIC CORP's revenue compounded faster (11.1% CAGR vs 4.2%).

PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

PCH vs TECH — Head-to-Head

Bigger by revenue
PCH
PCH
1.1× larger
PCH
$314.2M
$295.9M
TECH
Growing faster (revenue YoY)
PCH
PCH
+29.6% gap
PCH
23.1%
-6.4%
TECH
Higher net margin
TECH
TECH
4.6% more per $
TECH
12.8%
8.2%
PCH
Faster 2-yr revenue CAGR
PCH
PCH
Annualised
PCH
11.1%
4.2%
TECH

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
PCH
PCH
TECH
TECH
Revenue
$314.2M
$295.9M
Net Profit
$25.9M
$38.0M
Gross Margin
18.2%
64.6%
Operating Margin
11.2%
18.4%
Net Margin
8.2%
12.8%
Revenue YoY
23.1%
-6.4%
Net Profit YoY
682.5%
68.3%
EPS (diluted)
$0.33
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PCH
PCH
TECH
TECH
Q4 25
$295.9M
Q3 25
$314.2M
Q2 25
$275.0M
$317.0M
Q1 25
$268.3M
$316.2M
Q4 24
$258.1M
$297.0M
Q3 24
$255.1M
$289.5M
Q2 24
$320.7M
$306.1M
Q1 24
$228.1M
$303.4M
Net Profit
PCH
PCH
TECH
TECH
Q4 25
$38.0M
Q3 25
$25.9M
Q2 25
$7.4M
$-17.7M
Q1 25
$25.8M
$22.6M
Q4 24
$5.2M
$34.9M
Q3 24
$3.3M
$33.6M
Q2 24
$13.7M
$40.6M
Q1 24
$-305.0K
$49.1M
Gross Margin
PCH
PCH
TECH
TECH
Q4 25
64.6%
Q3 25
18.2%
Q2 25
13.0%
62.7%
Q1 25
17.8%
67.9%
Q4 24
13.4%
65.3%
Q3 24
10.8%
63.2%
Q2 24
11.9%
66.4%
Q1 24
7.0%
67.4%
Operating Margin
PCH
PCH
TECH
TECH
Q4 25
18.4%
Q3 25
11.2%
Q2 25
5.0%
-7.5%
Q1 25
10.3%
12.2%
Q4 24
5.2%
16.0%
Q3 24
2.8%
13.8%
Q2 24
5.4%
15.0%
Q1 24
-2.1%
22.1%
Net Margin
PCH
PCH
TECH
TECH
Q4 25
12.8%
Q3 25
8.2%
Q2 25
2.7%
-5.6%
Q1 25
9.6%
7.1%
Q4 24
2.0%
11.7%
Q3 24
1.3%
11.6%
Q2 24
4.3%
13.3%
Q1 24
-0.1%
16.2%
EPS (diluted)
PCH
PCH
TECH
TECH
Q4 25
$0.24
Q3 25
$0.33
Q2 25
$0.09
$-0.11
Q1 25
$0.33
$0.14
Q4 24
$0.07
$0.22
Q3 24
$0.04
$0.21
Q2 24
$0.17
$0.26
Q1 24
$0.00
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PCH
PCH
TECH
TECH
Cash + ST InvestmentsLiquidity on hand
$88.8M
$172.9M
Total DebtLower is stronger
$260.0M
Stockholders' EquityBook value
$1.9B
$2.0B
Total Assets
$3.2B
$2.5B
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PCH
PCH
TECH
TECH
Q4 25
$172.9M
Q3 25
$88.8M
Q2 25
$95.3M
$162.2M
Q1 25
$147.5M
$140.7M
Q4 24
$151.6M
$177.5M
Q3 24
$161.1M
$187.5M
Q2 24
$199.7M
$152.9M
Q1 24
$180.2M
$145.3M
Total Debt
PCH
PCH
TECH
TECH
Q4 25
$260.0M
Q3 25
Q2 25
$346.0M
Q1 25
$330.0M
Q4 24
$1.0B
$300.0M
Q3 24
$300.0M
Q2 24
$319.0M
Q1 24
$389.0M
Stockholders' Equity
PCH
PCH
TECH
TECH
Q4 25
$2.0B
Q3 25
$1.9B
Q2 25
$1.9B
$1.9B
Q1 25
$2.0B
$2.0B
Q4 24
$2.0B
$2.1B
Q3 24
$2.1B
$2.1B
Q2 24
$2.1B
$2.1B
Q1 24
$2.2B
$2.0B
Total Assets
PCH
PCH
TECH
TECH
Q4 25
$2.5B
Q3 25
$3.2B
Q2 25
$3.2B
$2.6B
Q1 25
$3.3B
$2.6B
Q4 24
$3.3B
$2.7B
Q3 24
$3.3B
$2.7B
Q2 24
$3.4B
$2.7B
Q1 24
$3.4B
$2.7B
Debt / Equity
PCH
PCH
TECH
TECH
Q4 25
0.13×
Q3 25
Q2 25
0.18×
Q1 25
0.16×
Q4 24
0.51×
0.14×
Q3 24
0.14×
Q2 24
0.15×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PCH
PCH
TECH
TECH
Operating Cash FlowLast quarter
$65.7M
Free Cash FlowOCF − Capex
$50.1M
FCF MarginFCF / Revenue
15.9%
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
2.54×
TTM Free Cash FlowTrailing 4 quarters
$132.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PCH
PCH
TECH
TECH
Q4 25
Q3 25
$65.7M
Q2 25
$41.0M
$98.2M
Q1 25
$49.1M
$41.1M
Q4 24
$45.4M
$84.3M
Q3 24
$26.5M
$63.9M
Q2 24
$100.6M
$75.5M
Q1 24
$16.0M
$81.0M
Free Cash Flow
PCH
PCH
TECH
TECH
Q4 25
Q3 25
$50.1M
Q2 25
$30.6M
$93.3M
Q1 25
$26.3M
$31.0M
Q4 24
$25.4M
$77.5M
Q3 24
$-8.2M
$54.7M
Q2 24
$72.4M
$57.5M
Q1 24
$2.0M
$64.5M
FCF Margin
PCH
PCH
TECH
TECH
Q4 25
Q3 25
15.9%
Q2 25
11.1%
29.4%
Q1 25
9.8%
9.8%
Q4 24
9.9%
26.1%
Q3 24
-3.2%
18.9%
Q2 24
22.6%
18.8%
Q1 24
0.9%
21.3%
Capex Intensity
PCH
PCH
TECH
TECH
Q4 25
Q3 25
4.9%
Q2 25
3.8%
1.5%
Q1 25
8.5%
3.2%
Q4 24
7.7%
2.3%
Q3 24
13.6%
3.2%
Q2 24
8.8%
5.9%
Q1 24
6.1%
5.4%
Cash Conversion
PCH
PCH
TECH
TECH
Q4 25
Q3 25
2.54×
Q2 25
5.58×
Q1 25
1.90×
1.82×
Q4 24
8.74×
2.42×
Q3 24
7.99×
1.90×
Q2 24
7.35×
1.86×
Q1 24
1.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PCH
PCH

Lumber$131.8M42%
Timberlands$52.5M17%
Rural Real Estate$51.3M16%
Residuals And Panels$34.0M11%
Pulpwood$16.7M5%
Development Real Estate$14.6M5%
Other$8.1M3%
Other Products$5.2M2%

TECH
TECH

Diagnostics And Spatial Biology$81.2M27%
EMEA Excluding UK$75.4M25%
Other$42.4M14%
Instruments$29.6M10%
APAC Excluding Greater China$22.7M8%
Services$22.3M8%
GB$13.7M5%
Royalty$8.5M3%

Related Comparisons